Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

EpiGenX Biosciences Inc (AKA: EpiGenX Pharmaceuticals )
Profile last edited on: 12/15/06      CAGE: 4GS57      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2001
First Award
2001
Latest Award
2004
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

320 North Nopal Street
Santa Barbara, CA 93103
   (805) 797-6967
   judym@epigenxbiosciences.com
   www.epigenxbiosciences.com
Location: Single
Congr. District: 24
County: Santa Barbara

Public Profile

Formerly known as EpiGenX Pharmaceuticals, EpiGenX Biosciences Inc develops epigenetic-based diagnostics and therapies tailored to the needs of individual patients. Epigenetic strategies entail developing an advanced understanding of gene regulation, and manipulating gene regulation in order to fight disease, particularly cancer and infections

Extent of SBIR involvement

User Avatar
Phase I Awards
5
Phase II Awards
4
Conversion Rate
80.00%
Phase I Dollars
$714,379
Phase II Dollars
$1,695,802
Total Awarded
$2,410,181

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2004 2 NIH $841,442
Project Title: DAM Inhibitors: A new class of antibiotics
2004 2 NIH $809,917
Project Title: Development of Inhibitors of the DNA Methylation Process
2003 2 NIH $455,654
Project Title: Development of DNA Methyltransferase Inhibitors as Anti*
2002 1 NIH $100,168
Project Title: Technology for Genome-Wide Cancer Methylation Profiling
2002 2 NIH $203,000
Project Title: Whole Genome Methylation Assay

Key People / Management

  Larry O Bymaster -- President

  Oddur Ingolfsson

  Paul H Johnson

  Judy A Mikovits

  Norbert O Reich

Company News

There are no news available.